134 related articles for article (PubMed ID: 2355639)
21. [Pancreatic cancer and tumor markers].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
[No Abstract] [Full Text] [Related]
22. [Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice].
Skvortsov SV; Lytsar' BN; Kalinin AV; Dolinskiĭ AG
Klin Med (Mosk); 1992; 70(5-6):21-3. PubMed ID: 1279265
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of elastase 1 assay as a tumor marker].
Kimura T; Nawata H
Nihon Rinsho; 1990 Feb; 48 Suppl():899-902. PubMed ID: 2355631
[No Abstract] [Full Text] [Related]
24. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
[TBL] [Abstract][Full Text] [Related]
25. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
Chen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
[No Abstract] [Full Text] [Related]
27. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
29. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic and biliary tract cancers].
Sawada T; Yamada N; Hirakawa K
Gan To Kagaku Ryoho; 2001 Jun; 28(6):865-71. PubMed ID: 11432359
[TBL] [Abstract][Full Text] [Related]
31. [CA 19-9, a new tumor marker].
Akai S
Rinsho Byori; 1983 Dec; 31(12):1300-2. PubMed ID: 6587136
[No Abstract] [Full Text] [Related]
32. [CA72-4 (TAG-72)].
Maida Y; Kyo S; Inoue M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
[No Abstract] [Full Text] [Related]
33. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
Ishii M
Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
[TBL] [Abstract][Full Text] [Related]
34. CA 242--a step ahead.
Shahi SK; Ranga S; Bhullar C
Indian J Pathol Microbiol; 2002 Apr; 45(2):145-6. PubMed ID: 12696727
[No Abstract] [Full Text] [Related]
35. [Evaluation of KMO1 for the gastrointestinal disease].
Okumura S; Ohyanagi H; Saitoh Y
Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
[No Abstract] [Full Text] [Related]
36. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
[TBL] [Abstract][Full Text] [Related]
37. Tumor markers in pancreatic cancer--current concepts.
Schmiegel W
Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
[TBL] [Abstract][Full Text] [Related]
38. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
39. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
40. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
